What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing stroke cases.

What are the key drivers of the Intracranial Thrombectomy Stent market?

Key drivers include rising demand for minimally invasive procedures and technological advancements in stent design.

What are the major challenges facing the market?

Challenges include high procedure costs, limited reimbursement, and risks associated with stent deployment.

Which regions are leading the Intracranial Thrombectomy Stent market?

North America and Europe are leading the market, driven by established healthcare infrastructure.

Who are the top companies in the Intracranial Thrombectomy Stent market?

Top companies include Medtronic, Stryker, and Boston Scientific, offering innovative stent solutions.

What future opportunities can be expected in the market?

Future opportunities include emerging markets, increasing adoption of stent-based treatments, and advancements in stent technology.

How will technology impact the Intracranial Thrombectomy Stent market?

Advances in materials, design, and navigation systems will improve stent efficacy, driving market growth and future outlook.

What is the current regulatory landscape for the market?

The regulatory landscape is governed by FDA and CE mark approvals, ensuring safety and efficacy of stent devices.

What is the expected future outlook for the Intracranial Thrombectomy Stent market?

The future outlook is positive, with increasing adoption of stent-based treatments and rising demand for minimally invasive procedures.

Intracranial Thrombectomy Stent Market Potential & Strategic Outlook 2033

Intracranial Thrombectomy Stent by Application (Hospital, Clinic, Other), by Types (3MM*20MM, 6MM*25MM, 6MM*40MM, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Intracranial Thrombectomy Stent Market Size | CAGR 0.075 Forecast 2033

Intracranial Thrombectomy Stent Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Intracranial Thrombectomy Stent Market Overview

The Intracranial Thrombectomy Stent market refers to the global market for devices used to remove blood clots from the brain. As the Intracranial Thrombectomy Stent market size is expected to grow significantly, driven by an increasing growth outlook and market forecast, industry players are focusing on industry expansion through innovative products and strategic partnerships. The scope of this market includes mechanical thrombectomy devices, stent retrievers, and aspiration catheters, which are used to treat acute ischemic stroke and other cerebrovascular diseases. The current Intracranial Thrombectomy Stent market size is approximately $1.4 billion, with a projected growth forecast of 8-10% CAGR during the forecast period from 2026 to 2033. The market is driven by macro drivers such as an increasing stroke incidence, technological advancements, and regulatory approvals. Key forces shaping the industry include technology shifts towards more efficient and minimally invasive procedures, regulations governing device safety and efficacy, and competitive intensity among market players.

Loading chart…

The largest region in the Intracranial Thrombectomy Stent market is North America, driven by a high stroke incidence and reimbursement rates. The fastest-growing region is Asia-Pacific, driven by an increasing stroke incidence and expanding healthcare infrastructure. Key forces shaping the industry include consumer behavior towards more minimally invasive procedures, supply-chain dynamics affecting device availability, and competitive intensity among market players. As the market continues to evolve, industry players must focus on innovative products, strategic partnerships, and regulatory compliance to remain competitive and drive industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	1.24 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MicroPort NeuroTech; Zylox Tonbridge; Skynor Medical; Genesis MedTech; Heart Care; Hemo China; Vesalio; Micro Therapeutics; Stryker; Medtronic; JNJ; Acandis; JiaJiangsu Niko Medical Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Intracranial Thrombectomy Stent market is poised for significant growth, driven by factors that are reshaping the healthcare landscape. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in stent technology are improving the efficacy and safety of intracranial thrombectomy procedures, leading to increased adoption rates and contributing to the growth of the Intracranial Thrombectomy Stent market size.

The rising prevalence of stroke and other cerebrovascular diseases is driving demand for effective treatment options, thereby fueling the growth forecast of the Intracranial Thrombectomy Stent market.

Restraints2 items

High procedure costs and limited reimbursement options in some regions are constraining the growth of the Intracranial Thrombectomy Stent market, making it challenging for patients to access these life-saving treatments.

Stringent regulatory requirements for the approval of new intracranial thrombectomy stents can slow down the entry of innovative products into the market, affecting the overall growth trajectory of the Intracranial Thrombectomy Stent market size.

Opportunities2 items

Emerging markets in Asia and Latin America offer significant opportunities for the expansion of the Intracranial Thrombectomy Stent market, driven by growing healthcare infrastructure and increasing awareness about advanced stroke treatments.

The development of next-generation stents with enhanced features such as improved deliverability and reduced complication rates can further boost the growth forecast of the Intracranial Thrombectomy Stent market.

Challenges2 items

The Intracranial Thrombectomy Stent market faces challenges from competitive technologies such as mechanical thrombectomy devices, which can potentially cannibalize market share if they demonstrate superior efficacy or safety profiles.

Ensuring supply chain resilience and managing the pricing strategy effectively are critical for market players to maintain profitability and competitiveness in the Intracranial Thrombectomy Stent market.

Market Segmentation

Loading chart…

The Intracranial Thrombectomy Stent market can be segmented based on Application, which includes subtypes such as ischemic stroke and cerebral venous sinus thrombosis. This segmentation is crucial in understanding the Intracranial Thrombectomy Stent segmentation as it helps in identifying the specific areas of application where the stents are most effective. The application segment contributes significantly to the overall market size, with ischemic stroke being the primary indication for intracranial thrombectomy stent procedures.

The Types segment of the Intracranial Thrombectomy Stent market includes subtypes such as retrievable stents and non-retrievable stents. This segmentation is essential in determining the market size and growth prospects, as each subtype has its own set of advantages and disadvantages. The retrievable stents are further divided into subtypes, including [object Object] and [object Object], which are designed to provide improved efficacy and safety in intracranial thrombectomy procedures. Understanding the market taxonomy of these subtypes is critical in assessing the overall market potential.

Intracranial Thrombectomy Stent Segmentation Breakdown9 items

Application

Hospital

Clinic

Other

Types

3MM*20MM

6MM*25MM

6MM*40MM

Other

Regional Insights

Loading chart…

The Intracranial Thrombectomy Stent market growth is anticipated to vary across regions, with North America being the largest region, holding approximately 40% of the market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include high adoption rates of Intracranial Thrombectomy Stent procedures, well-established infrastructure, and a mature ecosystem. In Europe, drivers include growing demographics with an aging population, increasing investments in healthcare, and favorable policies supporting medical device innovation. Asia Pacific is driven by rapid infrastructure development, rising adoption of advanced medical technologies, and significant investments in healthcare. Latin America and Middle East & Africa are expected to be driven by increasing adoption and growing demographics, although at a slower pace due to infrastructure and ecosystem challenges.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by policies supporting medical device innovation, increasing investments in healthcare, and growing demographics. Understanding these regional dynamics is crucial for stakeholders to navigate the Intracranial Thrombectomy Stent market and capitalize on emerging opportunities.

Competitive Landscape

The Intracranial Thrombectomy Stent market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Intracranial Thrombectomy Stent competitive landscape is driven by companies seeking to differentiate themselves through innovative products and strategic partnerships. Key competitive levers include pricing strategies, robust distribution networks, and investments in research and development to enhance product portfolios.

Companies in this space employ various strategies to gain a competitive edge, including mergers and acquisitions, partnerships, product launches, expansion into new markets, and investments in research and development to improve localization and customization capabilities. However, they face challenges such as margin pressure, compliance costs, and the risk of commoditization. To mitigate these risks, companies focus on differentiating their offerings through advanced technology, superior service models, strong channel presence, and cost advantages. The following companies illustrate different strategic focuses:

MicroPort NeuroTech: Regional expansion

Zylox Tonbridge: Premium pricing

Skynor Medical: Innovation pipeline

Genesis MedTech: Local manufacturing

Heart Care: OEM tie-ups

Hemo China: Vertical integration

Key Intracranial Thrombectomy Stent Companies13 items

MicroPort NeuroTech

Zylox Tonbridge

Skynor Medical

Genesis MedTech

Heart Care

Hemo China

Vesalio

Micro Therapeutics

Stryker

Medtronic

JNJ

Acandis

JiaJiangsu Niko Medical Devices

Market Ecosystem

The Intracranial Thrombectomy Stent ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. The ecosystem boundaries are defined by the flow of value creation and capture, with technology providers and suppliers delivering components and materials to original equipment manufacturers (OEMs) and manufacturers, who then integrate these into finished products. These products are subsequently distributed through various channels to end users, including hospitals and healthcare providers. A thorough value chain analysis is essential to understanding the intricacies of the Intracranial Thrombectomy Stent ecosystem.

Raw material/component suppliers — provide critical materials

OEMs / manufacturers — design and produce stent devices

Technology providers — develop underlying technologies

System integrators / EPCs — integrate stent devices into healthcare systems

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

The flow of value within the Intracranial Thrombectomy Stent ecosystem is influenced by various control points, including regulatory bodies that oversee device approvals and standards. Dependency risks, such as input constraints and standards compliance, can impact the supply chain and device adoption. Switching costs and interoperability requirements may also affect partnerships between ecosystem participants. Furthermore, regional differences in regulatory frameworks, healthcare systems, and market dynamics can lead to variations in the ecosystem across different regions, highlighting the need for a nuanced understanding of these factors to navigate the Intracranial Thrombectomy Stent ecosystem effectively.

Recent Industry Insights

The Intracranial Thrombectomy Stent industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Neuravi, have focused on advancing stroke treatment options. Furthermore, there have been notable mergers and acquisitions, including the acquisition of Penumbra by Boston Scientific, which has expanded the company's portfolio of neurovascular products.

In terms of product launches, companies like Stryker have introduced new Intracranial Thrombectomy Stent systems, featuring improved design and functionality. Regulatory changes, such as the FDA's updated guidelines for stroke treatment devices, have also impacted the industry. Additionally, funding rounds and expansions have been secured by startups like Rapid Medical, which has received investments to develop innovative stroke treatment solutions, highlighting the shifting consumer and enterprise trends in the Intracranial Thrombectomy Stent industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Intracranial Thrombectomy Stent market outlook. The market exhibits moderate attractiveness due to a growing patient population and increasing awareness of stroke treatment options. Competitive intensity is relatively high, with key players investing heavily in research and development. The long-term outlook appears promising, driven by advancements in stent technology and expanding indications for thrombectomy procedures.

The innovation landscape is characterized by ongoing efforts to improve stent design, materials, and delivery systems. Demand-supply balance is expected to remain stable, with manufacturers ramping up production to meet rising demand. However, key risk factors include regulatory challenges, reimbursement uncertainties, and potential supply chain disruptions. Overall, the Intracranial Thrombectomy Stent market is poised for growth, offering opportunities for established players and new entrants alike.

12 items

1. Executive Summary

2. Intracranial Thrombectomy Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intracranial Thrombectomy Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Intracranial Thrombectomy Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Intracranial Thrombectomy Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Intracranial Thrombectomy Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Intracranial Thrombectomy Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Intracranial Thrombectomy Stent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Intracranial Thrombectomy Stent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Intracranial Thrombectomy Stent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Intracranial Thrombectomy Stent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Intracranial Thrombectomy Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intracranial Thrombectomy Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intracranial Thrombectomy Stent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Intracranial Thrombectomy Stent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Intracranial Thrombectomy Stent Market Competition by Key Manufacturers

9.1. Global Intracranial Thrombectomy Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Intracranial Thrombectomy Stent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. MicroPort NeuroTech

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Zylox Tonbridge

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Skynor Medical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Genesis MedTech

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Heart Care

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hemo China

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Vesalio

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Micro Therapeutics

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Stryker

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Medtronic

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. JNJ

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Acandis

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. JiaJiangsu Niko Medical Devices

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intracranial Thrombectomy Stent Market

Figure 4: Global Intracranial Thrombectomy Stent Market: Drivers

Figure 5: Global Intracranial Thrombectomy Stent Market: Challenges

Figure 6: Global Intracranial Thrombectomy Stent Market: Trends

Figure 7: Global Intracranial Thrombectomy Stent Market: Opportunity

Figure 8: Global Intracranial Thrombectomy Stent Market: Restraint

Figure 9: Global Intracranial Thrombectomy Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Intracranial Thrombectomy Stent Market Value (USD Million) By Region

Figure 19: Global Intracranial Thrombectomy Stent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Intracranial Thrombectomy Stent Market Value (USD Million) By Region

Figure 27: Global Intracranial Thrombectomy Stent Market Share (%) By: Regions (2032)

Figure 28: Global Intracranial Thrombectomy Stent Market Volume (K) By Region

Figure 29: Global Intracranial Thrombectomy Stent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Intracranial Thrombectomy Stent Market Value (USD Million) By Region

Figure 37: Global Intracranial Thrombectomy Stent Market Share (%) By: Regions (2032)

Figure 38: Global Intracranial Thrombectomy Stent Market Volume (K) By Region

Figure 39: Global Intracranial Thrombectomy Stent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Intracranial Thrombectomy Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intracranial Thrombectomy Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intracranial Thrombectomy Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Intracranial Thrombectomy Stent Market Value (USD Million) By Region

Table 14: Global Intracranial Thrombectomy Stent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Intracranial Thrombectomy Stent Market Volume (K) By Region

Table 31: Global Intracranial Thrombectomy Stent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Intracranial Thrombectomy Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Intracranial Thrombectomy Stent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Intracranial Thrombectomy Stent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: MicroPort NeuroTech Basic Information And Sales Area

Table 52: MicroPort NeuroTech. Products Portfolio

Table 53: Zylox Tonbridge Basic Information And Sales Area

Table 54: Zylox Tonbridge. Products Portfolio

Table 55: Skynor Medical Basic Information And Sales Area

Table 56: Skynor Medical. Products Portfolio

Table 57: Genesis MedTech Basic Information And Sales Area

Table 58: Genesis MedTech. Products Portfolio

Table 59: Heart Care Basic Information And Sales Area

Table 60: Heart Care. Products Portfolio

Table 61: Hemo China Basic Information And Sales Area

Table 62: Hemo China. Products Portfolio

Table 63: Vesalio Basic Information And Sales Area

Table 64: Vesalio. Products Portfolio

Table 65: Micro Therapeutics Basic Information And Sales Area

Table 66: Micro Therapeutics. Products Portfolio

Table 67: Stryker Basic Information And Sales Area

Table 68: Stryker. Products Portfolio

Table 69: Medtronic Basic Information And Sales Area

Table 70: Medtronic. Products Portfolio

Table 71: JNJ Basic Information And Sales Area

Table 72: JNJ. Products Portfolio

Table 73: Acandis Basic Information And Sales Area

Table 74: Acandis. Products Portfolio

Table 75: JiaJiangsu Niko Medical Devices Basic Information And Sales Area

Table 76: JiaJiangsu Niko Medical Devices. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Intracranial Thrombectomy Stent Market Value (USD Million) By Region

Table 86: Global Intracranial Thrombectomy Stent Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Intracranial Thrombectomy Stent Market Volume (K) By Region

Table 103: Global Intracranial Thrombectomy Stent Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Intracranial Thrombectomy Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	1.24 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MicroPort NeuroTech; Zylox Tonbridge; Skynor Medical; Genesis MedTech; Heart Care; Hemo China; Vesalio; Micro Therapeutics; Stryker; Medtronic; JNJ; Acandis; JiaJiangsu Niko Medical Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options